Pharmaceuticals & Biotechnology | Pharma & Biotech Resources
Summary: Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community Through Pharma IQ, you will be able to access pharmaceutical information resources such as
- Visit Website
- RSS
- Artist: Unknown
Podcasts:
Stig Moller Christensen, International Planning and CRO Manager at ALK-Abelló, joins Dr. Gabriele Dallmann, CEO of Pharmatching GmbH, to discuss patient recruitment & retention strategies. He outlines the most crucial factors for pivotal studies and what he expects the sponsor
Ansgar Hebborn, Head of the Global Payer & HTA Program Policy at F Hoffmann-La Roche, joins Tim Haïdar from Pharma IQ, to analyse major trends and implications for the research-based pharmaceutical industry. Firstly he sums up who decides on what constitutes value in
Chris Archer from Pharma IQ, speaks exclusively with Terrell Herzig, Adjunct Professor of Health Informatics, University of Alabama at Birmingham, UAB Health System. The interview explores how the UAB laboratory has implemented iPad technology and how this is achieving multi-system
David Elder, Externalisation Director for GlaxoSmithKline and Pharma IQ Advisory Board Member, joins Andrea Charles from Pharma IQ, to discuss the most critical unmet drug delivery need and the benefits of early formulation testing. Elder shares his insights on how he thinks
Larry Blankstein, Sr. Director Clinical Research at Genzyme, joins Andrea Charles from Pharma IQ, to discuss resource management and clinical outsourcing. Blankstein talks about the challenges he faces in his clinical outsourcing today and shares his top three tips
What strategies are pharmaceutical companies employing to accelerate early development and preformulation? Michael Mitchell, Head of Pharmaceutical Sciences Oss, Merck, speaks to Andrea Charles from Pharma IQ, about current preformulation strategies and outsourcing early formulation
Lipid formulations have gained momentum in recent years as an efficient means for improving solubility of new chemical entities, but ensuring the stability of these systems can prove challenging. Dr. David Hauss, Principal of Hauss Associates, has written a book on oral lipid
Outsourcing various elements of formulation work has obvious advantages, but there are also some common pitfalls. Martin Schubert, Formulation Group Leader at UCB, joins Helen Winsor from Pharma IQ, to discuss developments and challenges in formulation. From own
Joachim Tedroff, Head of Clinical Science at NeuroSearch Sweden AB, joins Helen Winsor from Pharma IQ, to discuss strategies for optimising clinical development in CNS. First Tedroff outlines what he sees as the major challenges in the development of CNS therapies coming onto the
Joachim Tedroff, Head of Clinical Science at NeuroSearch Sweden AB, joins Helen Winsor from Pharma IQ, to discuss strategies for optimising clinical development in CNS. First Tedroff outlines what he sees as the major challenges in the development of CNS therapies coming onto the
As more medical devices incorporate flat flexible cables (FFC), polymer thick film circuits (PTF), and flexible printed circuits (FPC), what can engineers do from an interference perspective? Glen Griffith, Principal RF Communication Engineer, Alfred Mann Foundation, talks to Andrea
As part of the Pharma Leaders Today Series Dr. Akhilesh Sharma, Senior Vice President, Clinical (R&D), Piramal Life Sciences, speaks to Andrea Charles from PharmaIQ, about the unique challenges facing the Indian clinical R&D market and how the industry and regulators
Johannes Streffer, Director, Experimental Medicine Europe, Janssen Research & Development, Janssen Pharmaceutica NV, speaks to Andrea Charles from Pharma IQ, about where he feels the focus really lies at the moment for experimental medicine in Alzheimer’s disease.
In diesem Podcast spricht Thomas Brückner, Leiter des Geschäftsfeldes Pharmazie, Besondere Therapierichtungen und Medizinprodukte bei der Bundesverband der Pharmazeutischen Industrie e.V., über die Herausforderungen, die mit den Regelungen EU-Pharmapakets auf die
As part of the new Pharma Leaders Today series, Philip C. Strassburger, V.P., Intellectual Property Counsel at Purdue Pharma, spoke to Andrea Charles from Pharma IQ, about what trends he is currently seeing in pharmaceutical and biotech patents and overcoming
